Cargando…
Isavuconazole Kinetic Exploration for Clinical Practice
BACKGROUND: Isavuconazole is a new antifungal prodrug for the treatment of invasive aspergillosis and mucormycosis. As no clear pharmacokinetic-pharmacodynamic relationship has been established for patients, therapeutic drug monitoring is not currently required. However, as isavuconazole is a new dr...
Autores principales: | Darnaud, Léa, Lamoureux, Fabien, Godet, Cendrine, Pontier, Sandrine, Debard, Alexia, Venisse, Nicolas, Martins, Pauline, Concordet, Didier, Gandia, Peggy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277320/ https://www.ncbi.nlm.nih.gov/pubmed/30306415 http://dx.doi.org/10.1007/s40268-018-0251-y |
Ejemplares similares
-
“De-Shrinking” EBEs: The Solution for Bayesian Therapeutic Drug Monitoring
por: Baklouti, Sarah, et al.
Publicado: (2022) -
Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation
por: Baklouti, Sarah, et al.
Publicado: (2023) -
Hypoalbuminemia and Pharmacokinetics: When the Misunderstanding of a Fundamental Concept Leads to Repeated Errors over Decades
por: Gandia, Peggy, et al.
Publicado: (2023) -
Preparation and physicochemical stability of 50 mg/mL hydroxychloroquine oral suspension in SyrSpend(Ⓡ) SF PH4 (dry)
por: Binson, Guillaume, et al.
Publicado: (2020) -
Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?
por: Concordet, Didier, et al.
Publicado: (2019)